Drexel University College of Medicine

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Drexel University College of Medicine sits in the top decile of US sponsors by registered trial count (#626 of 15,742 sponsors by registered trial count).

25 total trials none currently recruiting 17 completed early-phase tilt top decile by trial count

Drexel University College of Medicine: 25 sponsored US clinical trials, none currently recruiting.

Drexel University College of Medicine sponsors 25 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 17 completed. 2 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Motor Neuron Disease, with 2 trials.

Top-decile sponsor footprint

Drexel University College of Medicine ranks in the top decile of sponsors by registered trial count (#626 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 9/100

17 of 25 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (68.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

25 total, page 1 of 1

COMPLETED Phase 2

Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer

NCT01467115
TERMINATED Phase 1

Effect of Intravenous Lidocaine, Used to Attenuate Pain With Propofol Injection, on Defibrillation Threshold Testing

NCT03117166
TERMINATED Phase 2

Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant

NCT00928811
COMPLETED NA

Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting

NCT00659737
TERMINATED

Pennsylvania Consortium: Clinical Database

NCT00718445
COMPLETED

Non-Invasive Assessment of Wound Healing With Optical Methods

NCT00578604
COMPLETED

Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population

NCT00718497
COMPLETED

EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)

NCT00718458
COMPLETED

Amyotrophic Lateral Sclerosis (ALS) Tissue Donation Program

NCT00716131
COMPLETED NA

Sacral Neuromodulation in Patients With IC

NCT00590473
TERMINATED

Comparison of Blood Pressure Throughout Pregnancy

NCT00452647
COMPLETED NA

Deployment of Functional Optical Brain Monitor [fNIR] in Clinical Anesthesia

NCT00448877
COMPLETED

TRIAD Project: Qualitative Study of Adolescent Depression and Smoking

NCT00592696
COMPLETED Phase 4

Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia

NCT01318408
TERMINATED

Quantitative Measurement of Nutritional Substrate Utilization in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00714220
COMPLETED

Cerebrospinal Fluid Repository

NCT00714636
COMPLETED Phase 2

Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS

NCT00579085
COMPLETED Phase 4

Ketamine Versus Etomidate for Procedural Sedation for Pediatric Orthopedic Reductions

NCT00596050
TERMINATED

Satisfaction Survey for Amyotrophic Lateral Sclerosis (ALS) Patients Comparing Rooms With and Without Assistive Technology

NCT00718107
TERMINATED

Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).

NCT00718003
TERMINATED

Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient

NCT00718016
COMPLETED Phase 2

Aripiprazole in Children With Autism: A Pilot Study

NCT00208533
COMPLETED Phase 2

Ziprasidone in Children With Autism: A Pilot Study

NCT00208559
COMPLETED Phase 1

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

NCT00003619
COMPLETED Phase 2

A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas

NCT00589706

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 6
Phase 4 2

Therapeutic Areas

Motor Neuron Disease 2
Neuro-Degenerative Disease 2
Amyotrophic Lateral Sclerosis 2
Cerebrospinal Fluid 1
Surgical Procedures, Operative 1
Conscious Sedation Failure During Procedure 1
Diabetic Foot Ulcers 1
Gliomas 1
Thrombocytopenia 1
Chronic Myeloproliferative Disorders 1

How the Drexel University College of Medicine early-phase archive is shaped

25 indexed studies, none listed as recruiting (0% open); 17 completed (68%).

Phase mix: 2 late (III/IV) vs 8 early (I/II) (early-phase heavy).

Top condition: Motor Neuron Disease (2 trials), 9 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Drexel University College of Medicine: archived-pipeline peers nationwide

Peers matched on 25 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Drexel University College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015202530 0%5%10%15% Total trials Recruiting share Drexel University College of MedicineArcus BiosciencesArcutis BiotherapeuticsArdelyxFisher and Paykel Healthcare10xBio22nd Century Group23andMe3-C Institute for Social Development
Drexel University College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Drexel University College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 25 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Drexel University College of Medicine page

25 registered trials is a research-attention snapshot, not an endorsement of Drexel University College of Medicine or any single study.

  • None of Drexel University College of Medicine's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Motor Neuron Disease is the condition Drexel University College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Motor Neuron Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Drexel University College of Medicine pipeline card: 25 registered trials from official public datasets.Report a data error.